HUMAX-CD20
USPTO Trademark Record · Serial No. 79026567
Trademark details
It was initially claimed by Genmab A/S on 20060228.
That brand applies to the following goods and services:Chemicals used in industry, science namely monoclonal antibodies for in vivo or in vitro scientific research and development regarding cancer, AIDS (acquired immune deficiency syndrome), and other infectious diseases, autoimmune diseases, and cardiovascular diseases, Pharmaceutical preparations based on human monoclonal antibodies for the treatment of cancer, AIDS (acquired immune deficiency syndrome), and other infectious diseases, autoimmune diseases, and cardiovascular diseases.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the HUMAX-CD20 trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
